Microfluidic Device May Replace Bone Marrow Biopsies for Myeloma
Patients with multiple myeloma soon may be diagnosed and followed solely with the use of a blood sample, avoiding the painful process of collecting a…
News
FDA Grants Tasquinimod Orphan Drug Status to Treat Multiple Myeloma
The small molecule immunomodulatory drug tasquinimod has been designated an orphan drug by the U.S. Food and Drug Administration (FDA) for the treatment of multiple…
Hematologist-Oncologist to Lead Innovative NYU Bone Marrow Transplant Initiative
Syrian-born hematologist-oncologist Ahmad Samer Al-Homsi, MD, MBA, will lead an innovative program at NYU Langone’s Perlmutter Cancer Center for treating blood cancers, including multiple…
Amgen Applies to FDA Requesting Approval of Xgeva to Treat Multiple Myeloma
Amgen submitted a supplemental Biologics Licence Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking to expand the indication of Xgeva…
Genetically Modified KITE-585 Therapy Increases Survival in Mice with Myeloma, Study Shows
Kite Pharma’s genetically modified T-cell therapy KITE-585 has delayed tumor progression and increased survival in mice with multiple myeloma, according to a preclinical-trial study. The…
Stem Cell Transplant with 3-Drug Combo Improved Progression-Free, But Not Overall Myeloma Survival
Treatment with Revlimid (lenalidomide), Velcade (bortezomib), and dexamethasone (RVD), in addition to a stem cell transplant, improved progression-free survival among multiple myeloma patients…
Poseida’s P-BCMA-101 Eliminates Tumors in Mice with Multiple Myeloma, Studies Show
Poseida Therapeutics‘ P-BCMA-101 eradicates tumors in mouse models of multiple myeloma and creates memory T-cells that go on the attack when the disease returns, preclinical…
Global Myeloma Action Network Declares March 30 International Myeloma Action Day
The patient-led Global Myeloma Action Network (GMAN) recently designated March 30 as International Myeloma Action Day to raise awareness of multiple myeloma, advocate for early detection and…
Leukemia & Lymphoma Society and Black Church Initiative Join to Help African-Americans with Myeloma
The Leukemia & Lymphoma Society (LLS) and the National Black Church Initiative (NBCI) are closing March, Myeloma Awareness Month, with the start of…
Multiple Myeloma Research Foundation Holds First Patient Summit in Denver
The first-ever Multiple Myeloma Research Foundation (MMRF) Patient Summit was held March 25 in Denver to help patients and caregivers learn more about…
